RxDoctor Payments Data

Yaping Wu, MD

Anatomic Pathology & Clinical Pathology · Vancouver, WANPI 1164504171

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $10,410 of the $15,678 with a category attached, or 66.4%. 13 manufacturers reported payments, led by Astellas Pharma US Inc at 31.1% of the total. Reporting peaked in 2020 at $7,545 and has fallen 99.0% since, to $78 in 2025. Among anatomic pathology & clinical pathology clinicians in WA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$15,678in general payments, 2019–2025

Across 31 payments — averaging $505.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Astellas Pharma US Inc$5K
  • Amgen$4K
  • AstraZeneca$3K
  • Roche Molecular Systems, Inc.$3K
  • Stemline Therapeutics Inc.$247
  • Roche Diagnostics Corporation$200
  • plus $759 from 7 others

What the payments were for

  • Consulting fees$10,41066%
  • Speaking & faculty fees$2,50016%
  • Travel & lodging$1,0277%
  • Food & beverage$1,74111%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$15,678 in reported general payments places this provider in the 90th percentile of 119 anatomic pathology & clinical pathology providers in Washington.

See all anatomic pathology & clinical pathology providers in Washington

Medicare billing

Part B allowed, 2024
$40,044
Medicare patients
187
Services billed
1,171

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other anatomic pathology & clinical pathology in Vancouver

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →